ArriVent BioPharma, Inc. (AVBP)
Across 9 earnings reports since Mar 28, 2024, ArriVent BioPharma, Inc. (AVBP) has a clear post-earnings pattern. It moves ±4.06% on average after reporting and finishes higher 33.3% of the time. Its largest post-earnings gain was +3.08% (Nov 10, 2025) and its largest decline was -11.86% (Nov 14, 2024). The next earnings report is predicted for 2026-08-12 (approximate).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
9
Avg Abs. Movement
±4.06%
Positive %
33.3%
Negative %
66.7%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| Mar 05, 2026 | ☽ POST | $25.74 | $25.99 | $25.25 | 599,200 | -7.21% | open_in_new |
| Nov 10, 2025 | ☀ PRE | $18.67 | $18.95 | $18.60 | 387,700 | +3.08% | open_in_new |
| Aug 11, 2025 | ☀ PRE | $18.23 | $18.23 | $17.39 | 523,500 | -3.34% | open_in_new |
| May 12, 2025 | ☀ PRE | $20.15 | $21.21 | $19.99 | 241,100 | -0.79% | open_in_new |
| Mar 03, 2025 | ☀ PRE | $23.55 | $23.65 | $22.03 | 369,900 | -6.69% | open_in_new |
| Nov 14, 2024 | ☀ PRE | $31.67 | $32.01 | $28.08 | 300,000 | -11.86% | open_in_new |
| Aug 14, 2024 | ☽ POST | $23.10 | $24.09 | $23.95 | 64,600 | -0.38% | open_in_new |
| May 08, 2024 | ☀ PRE | $16.82 | $17.85 | $17.36 | 40,800 | +0.64% | open_in_new |
| Mar 28, 2024 | ☽ POST | $17.85 | $18.30 | $17.86 | 233,200 | +2.52% | open_in_new |
Earnings Count
9
Total earnings in dataset
Avg Abs. Movement
±4.06%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| SCHEDULE 13G/A | 20260506 | open_in_new SEC.gov |
| ARS | 20260428 | open_in_new SEC.gov |
| DEFA14A | 20260428 | open_in_new SEC.gov |
| DEF 14A | 20260428 | open_in_new SEC.gov |
| ARS | 20260428 | open_in_new SEC.gov |
| DEF 14A | 20260428 | open_in_new SEC.gov |
| DEFA14A | 20260428 | open_in_new SEC.gov |
| 8-K | 20260317 | open_in_new SEC.gov |
| S-8 | 20260305 | open_in_new SEC.gov |
| 10-K | 20260305 | open_in_new SEC.gov |
Frequently asked about AVBP earnings
When does ArriVent BioPharma, Inc. report earnings next? expand_more
ArriVent BioPharma, Inc. (AVBP)'s next earnings date is approximate for 2026-08-12. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does AVBP stock move after earnings? expand_more
Over 9 reports, AVBP has moved an average of ±4.06% the session after earnings, closing higher 33.3% of the time.
What was AVBP's biggest post-earnings move? expand_more
AVBP's largest post-earnings gain on record was +3.08% on Nov 10, 2025, and its largest decline was -11.86% on Nov 14, 2024.
Where can I find ArriVent BioPharma, Inc.'s SEC filings? expand_more
All of ArriVent BioPharma, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right